Alliance for Cancer Gene Therapy (ACGT) will host its inaugural ACGT 2020 Cancer Summit on April 16, 2020 at the Alexandria Center for Life Science in New York City. The ACGT 2020 Cancer Summit — which launches ACGT’s 20th anniversary — will bring together researchers, companies, investors and advocates in cancer cell and gene therapy to discuss the latest advances, with a focus on combating solid tumors.
A partial list of ACGT 2020 Cancer Summit speakers includes:
Dara Richardson-Heron, MD – Chief Patient Officer, Pfizer
David Weinreich – Senior Vice President, Global Clinical Development, Regeneron
Maria Fardis, PhD, MBA – President and CEO, Iovance
Gavin Thurston – Vice President, Oncology & Angiogenesis, Regeneron
Mitchell H. Finer, PhD – Chief Scientific Officer, ElevateBio, Executive Partner MPM Capital
Peter Dudek, PhD – Partner, MRL Ventures Fund
Bruce Levine, PhD – Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania
Noriyuki Kasahara, MD, PhD – Professor, Neurological Surgery, UCSF
Tom Whitehead – Co-Founder, Emily Whitehead Foundation
Marc Hurlbert, PhD – Chief Scientific Officer, Melanoma Research Alliance
Kerri Kaplan – President & CEO, Lustgarten Foundation
Robert Levis – Director, CLL Society
Presenting sponsors include Alexandria Real Estate Equities, Inc./Alexandria Venture Investment. Additionally, STAT will be a media partner for the ACGT 2020 Cancer Summit. For more sponsorship information and early bird registration, please visit https://summit2020.acgtfoundation.org
Source: Alliance for Cancer Gene Therapy
Leave a Reply